Bristol Myers Squibb

Approved Evidence

Added to Rotten Company: 8/26/2026

Conduct/Event period: 1994–2005

Ongoing: No

Resolution status: Resolved

Resolution date: September 28, 2007

misconduct

Bristol Myers Squibb paid more than $515 million over illegal drug marketing and pricing allegations

Summary

Bristol-Myers Squibb and a subsidiary agreed to pay more than $515 million to resolve federal allegations involving illegal remuneration to healthcare providers, off-label promotion of Abilify, and drug-pricing practices that caused false claims to government healthcare programs. Source: https://www.justice.gov/archive/opa/pr/2007/September/07_civ_782.html

Evidence Weight

100.00

Severity:

Recency Weight: 99.99989820687469

File Weight: 1